These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 22389337)

  • 1. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ortegón M; Lim S; Chisholm D; Mendis S
    BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
    BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Stanciole AE; Ortegón M; Chisholm D; Lauer JA
    BMJ; 2012 Mar; 344():e608. PubMed ID: 22389338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Chisholm D; Saxena S
    BMJ; 2012 Mar; 344():e609. PubMed ID: 22389339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Chisholm D; Naci H; Hyder AA; Tran NT; Peden M
    BMJ; 2012 Mar; 344():e612. PubMed ID: 22389340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
    Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
    BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Baltussen R; Smith A
    BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies.
    Ranson MK; Jha P; Chaloupka FJ; Nguyen SN
    Nicotine Tob Res; 2002 Aug; 4(3):311-9. PubMed ID: 12215240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
    Baltussen R; Floyd K; Dye C
    BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.
    Adam T; Lim SS; Mehta S; Bhutta ZA; Fogstad H; Mathai M; Zupan J; Darmstadt GL
    BMJ; 2005 Nov; 331(7525):1107. PubMed ID: 16282407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model.
    Basu S; Flood D; Geldsetzer P; Theilmann M; Marcus ME; Ebert C; Mayige M; Wong-McClure R; Farzadfar F; Saeedi Moghaddam S; Agoudavi K; Norov B; Houehanou C; Andall-Brereton G; Gurung M; Brian G; Bovet P; Martins J; Atun R; Bärnighausen T; Vollmer S; Manne-Goehler J; Davies J
    Lancet Glob Health; 2021 Nov; 9(11):e1539-e1552. PubMed ID: 34562369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina.
    Rubinstein A; Colantonio L; Bardach A; Caporale J; Martí SG; Kopitowski K; Alcaraz A; Gibbons L; Augustovski F; Pichón-Rivière A
    BMC Public Health; 2010 Oct; 10():627. PubMed ID: 20961456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis.
    Bertram MY; Chisholm D; Watts R; Waqanivalu T; Prasad V; Varghese C
    Int J Health Policy Manag; 2021 Nov; 10(11):724-733. PubMed ID: 34273918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
    Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
    Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
    Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
    BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.